Private credit pressure builds as health care exposure deepens
Private credit is moving under a harsher spotlight. Wall Street banks are rolling out hedging instruments tied directly to private credit funds as investor anxiety grows around liquidity constraints, opaque valuations and rising stress across a $1.8 trillion market, Bloomberg reports. Regulators are taking note. The Federal Reserve has begun formally pressing large U.S. banks and insurers to disclose their exposure to private credit firms, signaling intensifying scrutiny as redemption pressures build and problem loans surface.
As a recent RSM The Real Economy Blog: Market Minute underscores, these developments signal an inflection point for private credit. For the health care industry—now one of the largest and most structurally dependent users of this capital—heightened volatility, tighter oversight and shifting lender behavior have increasingly material implications for balance sheets, financing flexibility and long‑term capital strategy.
Health care’s rising dependence on private credit
Health care has become the single largest sector for U.S. direct lending, accounting for roughly 22% of all direct lending issuance year‑to‑date through March 2026, up from 18% in 2025. Private credit has increasingly filled financing gaps for hospitals, physician platforms, behavioral health providers and post‑acute operators—supporting capital projects, acquisitions, technology investments and balance‑sheet refinancing when public markets or tax‑exempt debt were less accessible.
This growth has been fueled by health care’s defensive demand characteristics and predictable cash flows. However, as private credit funds face redemption requests and closer oversight, the reliability and cost of this capital source may change. But the very concentration that made health care attractive to lenders is now becoming a point of exposure.
Where the risks are emerging
For health care providers, the primary risk is capital availability. If private credit funds tighten underwriting standards, reduce leverage or limit new originations, providers could face delayed or canceled capital projects, higher borrowing costs or reduced flexibility in structuring transactions. Organizations with thin operating margins or heavy reliance on floating‑rate private debt may feel pressure first.
At the same time, health care represents a growing concentration risk for private credit lenders themselves. As recovery rates fall and underwriting assumptions are tested, lenders are increasingly focused on provider fundamentals—cash‑flow stability, payer mix, labor costs and governance. A slowdown in health care performance could amplify stress within private credit portfolios, particularly for highly levered funds facing redemption constraints.
Positioning for the next phase of the capital cycle
For health care organizations, this is a moment to shift from opportunistic financing to intentional capital strategy. Leading providers are reassessing balance sheet resilience under stressed‑rate and reduced‑availability scenarios. They are strengthening lender communications with clearer performance narratives and disciplined forecasting. Many are diversifying funding sources—balancing private credit with bank facilities, public debt, joint ventures and asset‑level structures—to preserve flexibility.
Above all, capital discipline is becoming a strategic differentiator. Investment decisions are being filtered through return thresholds, mission alignment and downside protection—not simply access.
Private credit is unlikely to disappear from health care finance. But the easy phase has passed. Providers that act now—before capital tightens further—will be better positioned for the next stage of this cycle.
Learn more about what’s happening in health care in our industry outlook.
